-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the UK, the new coronavirus pneumonia COVID-19 (SARS-CoV-2) has had a significant impact on cancer care, including systemic cancer treatment (SACT).
significant reduction in cancer screening, diagnostic testing or treatment has been observed during the pandemic.
early studies have shown an increased risk of SARS-CoV-2 infection in cancer patients, and that the SACT of patients is associated with the severity of COVID-19.
addition, it also makes patients' SATs more challenging while maintaining social distance.
patients increases the risk of transmission of infection between patients and health care providers.
these factors also create uncertainty for the clinical treatment of cancer.
therefore, studying the impact of the COVID-19 outbreak on THESACT is critical for the short- and long-term impact of cancer patients and future care.
the study, researchers reported real-time SAST data from Scotland in the NHS.
that patients' treatment attendance initially dropped by 28.7 percent, but then recovered quickly after the service system was redesigned.
systemic anti-cancer treatment (SACT) breast cancer patients in Scotland had the lowest (19.7 per cent) decline and the fastest recovery during the COVID-19 pandemic, while colorectal cancer patients had the largest decline (43.4 per cent).
the researchers observed regional differences in the extent of the impact on SAC delivery, but the lowest rates of decline occurred in time synchronization, and the recovery rates were similar in all regions.
SACT's rapid recovery reflects the co-ordination of national response strategies and counterpart structures for patients and relevant clinicians, which has also facilitated the creation of COVID-19 protected areas at cancer centres in Scotland for SACT delivery and the sharing of successful innovative strategies.
, the study demonstrated the impact of COVID-19 on SACT delivery in Scotland.
more research data also show that the adverse effects of the outbreak on cancer patients have been effectively improved through the creation of a corresponding COVID-19 protected SACT delivery system through temporary management arrangements for cancer drugs.
